FDA Inspection 1177604 — Paula K. Skarda, MD
The FDA completed an inspection of Paula K. Skarda, MD on Aug 5, 2022 in Saint Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 5, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint Paul, MN (United States)
Additional Details
Clinical Investigator (CI)